AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Oncolys BioPharma Inc.

¥5800 +$4306.00 (+288.22%)
JPX · 16 Sep 2026 06:30 UTC
Previous Close
¥6390
Day Range
¥5520¥6850
Year Range
¥601¥6850
Market Cap
169.84B
AVG Volume
1.39M
Trailing/Forward PE
-105.53/-
PEG ratio
-1.89
Dividend Yield
-
Next Earnings Date
2026-11-06
Primary Exchange
Tokyo Stock ExchangeJP
Revenue (JPY) · TTM
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
4588.T Revenue (JPY) · TTM by quarter
PeriodRevenue (JPY) · TTM
26 Q2503.09M
26 Q131.64M
25 Q428.55M
25 Q328.55M
25 Q228.55M
25 Q131.38M
24 Q431.38M
24 Q331.38M
24 Q231.38M
24 Q128.04M
Net Income (JPY) · TTM
-3B-2B-1B024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
4588.T Net Income (JPY) · TTM by quarter
PeriodNet Income (JPY) · TTM
26 Q2-1.51B
26 Q1-1.66B
25 Q4-2.06B
25 Q3-2.06B
25 Q2-2.24B
25 Q1-2.13B
24 Q4-1.68B
24 Q3-1.91B
24 Q2-1.82B
24 Q1-1.98B
Operating Income (JPY) · TTM
-3B-2B-1B024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
4588.T Operating Income (JPY) · TTM by quarter
PeriodOperating Income (JPY) · TTM
26 Q2-1.52B
26 Q1-1.66B
25 Q4-2.02B
25 Q3-2.02B
25 Q2-2.16B
25 Q1-2.09B
24 Q4-1.68B
24 Q3-1.85B
24 Q2-1.82B
24 Q1-1.98B
EBITDA (JPY) · TTM
-3B-2B-1B024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
4588.T EBITDA (JPY) · TTM by quarter
PeriodEBITDA (JPY) · TTM
26 Q2-1.51B
26 Q1-1.66B
25 Q4-2.05B
25 Q3-2.05B
25 Q2-2.18B
25 Q1-2.07B
24 Q4-1.62B
24 Q3-1.85B
24 Q2-1.82B
24 Q1-1.97B
Cash Flows (JPY) · TTM
020M40M60M80M23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
4588.T Cash Flows (JPY) · TTM by quarter
PeriodCash Flows (JPY) · TTM
25 Q46.1M
25 Q328.45M
25 Q231.92M
25 Q129.66M
24 Q425.63M
24 Q312.71M
24 Q213.18M
24 Q110.06M
23 Q410.06M
23 Q361.88M
EPS (JPY) · TTM
-150-100-50024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
4588.T EPS (JPY) · TTM by quarter
PeriodEPS (JPY) · TTM
26 Q2-54.96
26 Q1-63.28
25 Q4-81.78
25 Q3-82.5
25 Q2-93.11
25 Q1-91.64
24 Q4-77.22
24 Q3-94.45
24 Q2-95.07
24 Q1-107.82
Expenses (JPY) · TTM
01B2B3BR&DSG&A24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
4588.T Expenses (JPY) · TTM by quarter
PeriodExpenses (JPY) · TTM
26 Q22.03B
26 Q11.69B
25 Q42.05B
25 Q32.35B
25 Q22.48B
25 Q12.42B
24 Q42.01B
24 Q31.88B
24 Q21.85B
24 Q12.01B
Shares Outstanding · TTM
-80M-60M-40M-20M023 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
4588.T Shares Outstanding · TTM by quarter
PeriodShares Outstanding · TTM
25 Q4-6.1M
25 Q3-28.45M
25 Q2-31.92M
25 Q1-29.66M
24 Q4-25.63M
24 Q3-12.71M
24 Q2-13.18M
24 Q1-10.06M
23 Q4-10.06M
23 Q3-61.88M
Price to Sales
0200040006000med 599.73Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
4588.T Price to Sales by quarter
PeriodPrice to Sales
Sep 265913.6
Sep 265312.06
Sep 264252.42
Aug 264451.39
Aug 263128.01
Aug 263007.7
Aug 262635.67
Jul 262466.31
Jul 262284.92
Jul 262175.72
Jul 262383.02
Jul 262480.19
Jun 262462.99
Jun 262335.01
Jun 262223.27
Jun 262355.74
May 262491.82
May 262520.66
May 262415.22
May 262629.71
May 262448.57
Apr 262683.78
Apr 262577.44
Apr 262253.91
Apr 262042.12
Mar 262111.11
Mar 262028.04
Mar 262439.79
Mar 262844.31
Feb 262465.07
Feb 262000.05
Feb 262203.21
Feb 261691.24
Jan 261570.24
Jan 261632.55
Jan 261754.45
Jan 261371.59
Dec 251249.69
Dec 25958.35
Dec 25747.7
Dec 25923.53
Dec 25803.41
Nov 251021.89
Nov 25858.25
Nov 25907.86
Nov 25740.74
Oct 25651.08
Oct 25618.88
Oct 25609.3
Oct 25698.96
Oct 25590.15
Sep 25492.52
Sep 25499.65
Sep 25491.73
Sep 25512.32
Aug 25503.61
Aug 25563.79
Aug 25563.79
Aug 25476.68
Aug 25460.06
Jul 25468.77
Jul 25484.6
Jul 25505.98
Jul 25479.06
Jun 25491.57
Jun 25478.29
Jun 25479.07
Jun 25518.93
May 25487.67
May 25403.26
May 25414.2
May 25437.65
May 25448.59
Apr 25436.09
Apr 25452.5
Apr 25411.86
Apr 25415.77
Mar 25442.82
Mar 25538.66
Mar 25502.99
Mar 25485.5
Feb 25469.41
Feb 25435.83
Feb 25435.83
Feb 25398.75
Jan 25399.45
Jan 25379.16
Jan 25356.78
Jan 25362.37
Dec 24362.37
Dec 24355.13
Dec 24336.51
Dec 24436.26
Dec 24442.91
Nov 24461.53
Nov 24467.52
Nov 24497.44
Nov 24448.23
Nov 24432.27
Oct 24403.67
Price to Book
0204060med 11.9Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
4588.T Price to Book by quarter
PeriodPrice to Book
Sep 2652.07
Sep 2646.77
Sep 2637.44
Aug 2639.19
Aug 2627.54
Aug 2626.48
Aug 2623.21
Jul 2621.72
Jul 2620.12
Jul 2619.16
Jul 2620.98
Jul 2621.84
Jun 2617.58
Jun 2616.66
Jun 2615.87
Jun 2616.81
May 2617.78
May 2617.99
May 2617.24
May 2618.77
May 2617.47
Apr 2619.15
Apr 2618.39
Apr 2616.09
Apr 2614.57
Mar 2634.03
Mar 2632.69
Mar 2639.33
Mar 2645.85
Feb 2639.74
Feb 2632.24
Feb 2635.52
Feb 2627.26
Jan 2625.31
Jan 2626.32
Jan 2628.28
Jan 2622.11
Dec 2520.14
Dec 2519.01
Dec 2514.83
Dec 2518.32
Dec 2515.94
Nov 2520.27
Nov 2517.03
Nov 2518.01
Nov 2514.69
Oct 2512.92
Oct 2512.28
Oct 2512.09
Oct 2513.87
Oct 2511.71
Sep 257.97
Sep 258.08
Sep 257.95
Sep 258.29
Aug 258.14
Aug 259.12
Aug 259.12
Aug 257.71
Aug 257.44
Jul 257.58
Jul 257.84
Jul 258.18
Jul 257.75
Jun 255.61
Jun 255.45
Jun 255.46
Jun 255.92
May 255.56
May 254.6
May 254.72
May 254.99
May 255.12
Apr 254.97
Apr 255.16
Apr 254.7
Apr 254.74
Mar 257.08
Mar 258.61
Mar 258.04
Mar 257.76
Feb 257.51
Feb 256.97
Feb 256.97
Feb 256.38
Jan 256.39
Jan 256.06
Jan 255.71
Jan 255.79
Dec 245.79
Dec 247.87
Dec 247.45
Dec 249.66
Dec 249.81
Nov 2410.22
Nov 2410.35
Nov 2411.02
Nov 249.93
Nov 249.57
Oct 248.94
Oncolys BioPharma Inc.
4588.T
Stockpicker

Video analysis: 4588.T

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.